Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters

We are developing assays to image tissue-specific reporter gene expression in living mice by using optical methods and positron emission tomography. Approaches for imaging reporter gene expression depend on robust levels of mRNA and reporter protein. Attempts to image reporter gene expression driven by weak promoters are often hampered by the poor transcriptional activity of such promoters. Most tissue-specific promoters are weak relative to stronger but constitutively expressing viral promoters. In this study, we have validated methods to enhance the transcriptional activity of the prostate-specific antigen promoter for imaging by using a two-step transcriptional amplification (TSTA) system. We used the TSTA system to amplify expression of firefly luciferase (fl) and mutant herpes simplex virus type 1 thymidine kinase (HSV1-sr39tk) in a prostate cancer cell line (LNCaP). We demonstrate ≈50-fold (fl) and ≈12-fold (HSV1-sr39tk) enhancement by using the two-step approach. The TSTA system is observed to retain tissue selectivity. A cooled charge-coupled device optical imaging system was used to visualize the amplified fl expression in living mice implanted with LNCaP cells transfected ex vivo. These imaging experiments reveal a ≈5-fold gain in imaging signal by using the TSTA system over the one-step system. The TSTA approach will be a valuable and generalizable tool to amplify and noninvasively image reporter gene expression in living animals by using tissue-specific promoters. The approaches validated should have important implications for study of gene therapy vectors, cell trafficking, transgenic models, as well as studying development of eukaryotic organisms.

[1]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  J. Barrio,et al.  Monitoring gene therapy with reporter gene imaging. , 2001, Seminars in nuclear medicine.

[3]  E. Galun,et al.  Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  A. Belldegrun,et al.  Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors , 2001, Gene Therapy.

[5]  S. Fraser,et al.  Tracing transgene expression in living zebrafish embryos. , 2001, Developmental biology.

[6]  P. Jiang,et al.  Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Satyamurthy,et al.  8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  S S Gambhir,et al.  Use of positron emission tomography in animal research. , 2001, ILAR journal.

[9]  J. Mountz,et al.  Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  D. Nettelbeck,et al.  Gene therapy: designer promoters for tumour targeting. , 2000, Trends in genetics : TIG.

[11]  M. Black,et al.  A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[13]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[14]  S. Weitzman,et al.  Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer , 1999, Gene Therapy.

[15]  S. Cherry,et al.  Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals , 1999, Gene Therapy.

[16]  S. Cherry,et al.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Schwartz,et al.  Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences , 1999, Nature Biotechnology.

[18]  D. Nettelbeck,et al.  A strategy for enhancing the transcriptional activity of weak cell type-specific promoters , 1998, Gene Therapy.

[19]  S. Cherry,et al.  Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  J. Humm,et al.  Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. , 1998, Cancer research.

[21]  S. Narumiya,et al.  Expression: a Novel Approach for Cancer Gene Therapy Prostate-specific Amplification of Expanded Polyglutamine Updated Version Citing Articles E-mail Alerts Prostate-specific Amplification of Expanded Polyglutamine Expression: a Novel Approach for Cancer Gene Therapy1 , 2022 .

[22]  J. Roth,et al.  Evaluation of GAL4/TATA in Vivo , 1998, The Journal of Biological Chemistry.

[23]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[24]  F. Paillard.  The use of peripheral blood hematopoietic progenitors for human immunodeficiency virus gene therapy. , 1997, Human gene therapy.

[25]  J. Trapman,et al.  An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. , 1997, Molecular endocrinology.

[26]  A. Belldegrun,et al.  Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. , 1997, Cancer research.

[27]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[28]  R G Blasberg,et al.  Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. , 1996, Cancer research.

[29]  M. Busslinger,et al.  A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Carey,et al.  A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. , 1992, The EMBO journal.

[31]  The relative stability of selected herpes simplex virus type 1 mRNAs. , 1991, Virus research.

[32]  R. Jaenisch,et al.  A generic intron increases gene expression in transgenic mice , 1991, Molecular and cellular biology.

[33]  Michael Carey,et al.  A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives , 1990, Nature.

[34]  J. Leatherwood,et al.  A potent GAL4 derivative activates transcription at a distance in vitro. , 1990, Science.

[35]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[36]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.